Price Alert

MiMedx Group Inc. (MDXG)

NASDAQ: MDXG · Real-Time Price · USD

7.10

-0.05 (-0.70%)

At close: Aug 15, 2025, 3:59 PM

7.11

0.13%

After-hours: Aug 15, 2025, 04:20 PM EDT

MiMedx Statistics

Share Statistics

MiMedx has 147.96M shares outstanding. The number of shares has increased by 0.61% in one year.

Shares Outstanding	147.96M
Shares Change (YoY)	0.61%
Shares Change (QoQ)	0.23%
Owned by Institutions (%)	68.98%
Shares Floating	116.5M
Failed to Deliver (FTD) Shares	816
FTD / Avg. Volume	0.1%

Short Selling Information

The latest short interest is 5.52M, so 3.74% of the outstanding shares have been sold short.

Short Interest	5.52M
Short % of Shares Out	3.74%
Short % of Float	4.67%
Short Ratio (days to cover)	5.56

Valuation Ratios

The PE ratio is 33.33 and the forward PE ratio is 21.94. MiMedx's PEG ratio is -0.84.

PE Ratio	33.33
Forward PE	21.94
PS Ratio	4.05
Forward PS	2.5
PB Ratio	7.32
P/FCF Ratio	21.92
PEG Ratio	-0.84

Financial Ratio History

Enterprise Valuation

MiMedx has an Enterprise Value (EV) of 1.33B.

EV / Sales	3.82
EV / EBITDA	20.74
EV / EBIT	20.16
EV / FCF	20.68

Financial Position

The company has a current ratio of 4.21, with a Debt / Equity ratio of 0.13.

Current Ratio	4.21
Quick Ratio	3.69
Debt / Equity	0.13
Debt / EBITDA	0.39
Debt / FCF	0.39
Interest Coverage	58.51

Financial Efficiency

Return on Equity is 21.97% and Return on Invested Capital is 19.67%.

Return on Equity	21.97%
Return on Assets	16.07%
Return on Invested Capital	19.67%
Revenue Per Employee	$416.82K
Profits Per Employee	$50.68K
Employee Count	837
Asset Turnover	1.32
Inventory Turnover	2.52

Taxes

Income Tax	15.3M
Effective Tax Rate	26.7%

Stock Price Statistics

The stock price has increased by 12.62% in the last 52 weeks. The beta is 1.79, so MiMedx's price volatility has been higher than the market average.

Beta	1.79
52-Week Price Change	12.62%
50-Day Moving Average	6.51
200-Day Moving Average	7.61
Relative Strength Index (RSI)	55.25
Average Volume (20 Days)	782,506

Income Statement

In the last 12 months, MiMedx had revenue of 348.88M and earned 42.42M in profits. Earnings per share was 0.29.

Revenue	348.88M
Gross Profit	288.81M
Operating Income	58.87M
Net Income	42.42M
EBITDA	64.34M
EBIT	58.3M
Earnings Per Share (EPS)	0.29

Full Income Statement

Balance Sheet

The company has 104.42M in cash and 24.84M in debt, giving a net cash position of 79.57M.

Cash & Cash Equivalents	104.42M
Total Debt	24.84M
Net Cash	79.57M
Retained Earnings	-91.26M
Total Assets	291.11M
Working Capital	170.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 66.2M and capital expenditures -1.68M, giving a free cash flow of 64.52M.

Operating Cash Flow	66.2M
Capital Expenditures	-1.68M
Free Cash Flow	64.52M
FCF Per Share	0.44

Full Cash Flow Statement

Margins

Gross margin is 82.78%, with operating and profit margins of 16.87% and 12.16%.

Gross Margin	82.78%
Operating Margin	16.87%
Pretax Margin	16.42%
Profit Margin	12.16%
EBITDA Margin	18.44%
EBIT Margin	16.87%
FCF Margin	18.49%

Dividends & Yields

MDXG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	3%
FCF Yield	4.56%

Dividend Details

Analyst Forecast

The average price target for MDXG is $12, which is 70.2% higher than the current price. The consensus rating is "Buy".

Price Target	$12
Price Target Difference	70.2%
Analyst Consensus	Buy
Analyst Count	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	2.92
Graham Upside	-58.58%

Stock Splits

The last stock split was on Apr 2, 2008. It was a backward split with a ratio of 647:2000.

Last Split Date	Apr 2, 2008
Split Type	backward
Split Ratio	647:2000

Scores

Altman Z-Score	10.46
Piotroski F-Score	6